Price Alert

4D pharma (LBPS)

NASDAQ: LBPS · Real-Time Price · USD

1.65

0.00 (0.00%)

At close: Apr 24, 2025, 3:47 PM

4D pharma Statistics

Share Statistics

4D pharma has 0 shares outstanding. The number of shares has increased by 0.02% in one year.

Shares Outstanding	n/a
Shares Change (YoY)	0.02%
Shares Change (QoQ)	0.02%
Owned by Institutions (%)	n/a
Shares Floating	16.79M
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 73.64K, so 0% of the outstanding shares have been sold short.

Short Interest	73.64K
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.37

Valuation Ratios

The PE ratio is -1.69 and the forward PE ratio is null. 4D pharma's PEG ratio is -0.06.

PE Ratio	-1.69
Forward PE	n/a
PS Ratio	75.35
Forward PS	n/a
PB Ratio	1.67
P/FCF Ratio	-1.42
PEG Ratio	-0.06

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for 4D pharma.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.21, with a Debt / Equity ratio of 0.39.

Current Ratio	5.21
Quick Ratio	5.16
Debt / Equity	0.39
Debt / EBITDA	-0.43
Debt / FCF	-0.34
Interest Coverage	-54.01

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$6.77K
Profits Per Employee	$-301.3K
Employee Count	106
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-22K
Effective Tax Rate	0.07%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 3.27, so 4D pharma's price volatility has been higher than the market average.

Beta	3.27
52-Week Price Change	n/a
50-Day Moving Average	3.31
200-Day Moving Average	n/a
Relative Strength Index (RSI)	22.65
Average Volume (20 Days)	11,314

Income Statement

In the last 12 months, 4D pharma had revenue of 718K and earned -31.94M in profits. Earnings per share was -2.4.

Revenue	718K
Gross Profit	718K
Operating Income	-31.38M
Net Income	-31.94M
EBITDA	-30.03M
EBIT	-31.38M
Earnings Per Share (EPS)	-2.4

Full Income Statement

Balance Sheet

The company has 20.97M in cash and 12.8M in debt, giving a net cash position of 8.17M.

Cash & Cash Equivalents	20.97M
Total Debt	12.8M
Net Cash	8.17M
Retained Earnings	-180.17M
Total Assets	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -37.92M and capital expenditures -279K, giving a free cash flow of -38.2M.

Operating Cash Flow	-37.92M
Capital Expenditures	-279K
Free Cash Flow	-38.2M
FCF Per Share	-2.84

Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -4370.33% and -4448.19%.

Gross Margin	100%
Operating Margin	-4370.33%
Pretax Margin	-4451.25%
Profit Margin	-4448.19%
EBITDA Margin	-4181.89%
EBIT Margin	-4370.33%
FCF Margin	-5319.64%

Dividends & Yields

LBPS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for LBPS.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a